Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.290
-0.070 (-2.97%)
Apr 23, 2026, 1:12 PM EDT - Market open
Caribou Biosciences Employees
Caribou Biosciences had 97 employees as of December 31, 2025. The number of employees decreased by 50 or -34.01% compared to the previous year.
Employees
97
Change (1Y)
-50
Growth (1Y)
-34.01%
Revenue / Employee
$115,041
Profits / Employee
-$1,527,062
Market Cap
221.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 97 | -50 | -34.01% |
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Codexis | 146 |
| Nkarta | 108 |
| Keros Therapeutics | 78 |
| ALX Oncology Holdings | 43 |
| Fennec Pharmaceuticals | 35 |
| Elicio Therapeutics | 33 |
| Sol-Gel Technologies | 28 |
CRBU News
- 23 days ago - Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - GlobeNewsWire
- 6 weeks ago - Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample - Business Wire
- 2 months ago - Caribou Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR® - GlobeNewsWire
- 5 months ago - Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - GlobeNewsWire
- 5 months ago - Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today> - Benzinga